IL1B and metabolic dysfunction-associated steatotic liver disease: We found significant associations between CRP (OR, 1.41; 95% CI, 1.31‐1.51; P<0.001) (Figure 2A), IL-1β (OR, 1.08; 95% CI, 1.02‐1.14; P=0.006) (Figure 3A), IL-6 (OR, 1.50; 95% CI, 1.17‐1.92; P=0.001) (Figure 3B), TNF-α (OR, 1.15; 95% CI, 1.01‐1.31; P=0.031) (Figure 3C), and ICAM‐1 (OR, 2.17; 95% CI, 1.22‐3.85; P=0.008) (Figure 3D) and NAFLD.